New blog on MS treatment

Dalfampridine, 4-Aminopyridine, Ampyra, Fampridine or Neurelan as it is known is one of the latest ways of tackling the symptoms of multiple sclerosis or Lambert-Eaton myasthenic syndrome. If you have used this treatment or just want to find out more why not drop round to our new blog on the subject!

http://www.patient-experience.com/index.php/dalfampridine-a-treatment-for-multiple-sclerosis-and-lambert-eaton-myasthenic-syndrome/

The Patients Voice

The patient research community for patient information that champions YOUR VOICE

This is the Patient forum where patients, their families, carers and friends can participate in a wide variety of medical market research projects about health care.

The government, pharmaceutical companies and medical providers are interested in knowing people’s opinions to improve their services. That is why Patient’s rights and opinions about their treatments are fundamental to help pioneer the future services the health care sector provides.

This is where a medical market research panel like The Patients Voice comes in.
Please make your voice heard by joining our Patient research community, to participate in market research and provide us with your quality opinions about medical conditions that have affected you or your loved ones.

Membership of the Patients Voice is free and is open to anyone.

http://www.thepatientsvoice.org/reg_p1.asp